Sun Pharmaceutical Quarterly Results for Trading Insights

SUNPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹3,125 Cr
QSept 2025
Quarterly Results

Sun Pharmaceutical Quarterly Results Key Highlights

  • Revenue of ₹14,875 Cr in Sept 2025 (+10.8% vs Mar 2025, +9.2% vs Sept 2024)
  • Net Profit of ₹3,125 Cr in Sept 2025 (+45.1% vs Mar 2025, +2.9% vs Sept 2024)
  • EBITDA of ₹4,924 Cr in Sept 2025 (+28.8% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+6.0pp vs Mar 2025)
  • Earnings Per Share of ₹13.00 in Sept 2025 (+44.4% vs Mar 2025)

Sun Pharmaceutical Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 14,875 13,429 14,251 16,048 13,618 10.8% 9.2%
Net Profit (₹ Cr) 3,125 2,154 2,293 3,381 3,037 - -
EBITDA (₹ Cr) 4,924 3,824 3,883 4,986 4,266 - -
EPS (₹) 13.00 9.00 9.50 14.00 12.70 - -
Operating Margin (%) 31.0% 25.0% 25.0% 28.0% 29.0% - -

Sun Pharmaceutical Share Price Trend Around Quarterly Results

Visualize Sun Pharmaceutical's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Sun Pharmaceutical

Additional stock information and data for SUNPHARMA

SUNPHARMA company profile
SUNPHARMA PE ratio trends
SUNPHARMA price range

Profitability Ratios

Profit Margin 21.0%
EBITDA Margin 33.1%
Operating Margin 31.0%
ROE (Annual) 17.2%

Balance Sheet Highlights

Total Assets ₹92,101 Cr
Total Equity ₹72,486 Cr
Current Assets ₹52,594 Cr
Current Liabilities ₹1,420 Cr

Cash Flow Analysis

Operating Cash Flow ₹14,072 Cr
Investing Cash Flow ₹-5,183 Cr
Financing Cash Flow ₹-7,906 Cr
Net Cash Flow ₹983 Cr

Current Market Data

Current Price ₹1717.10
Exchange NSE
Last Updated Apr 09, 2026

Revenue Trend (₹ Cr)

Dec 2025 16,048
Jun 2025 14,251
Mar 2025 13,429
Sept 2025 14,875

Net Profit Trend (₹ Cr)

Dec 2025 3,381
Jun 2025 2,293
Mar 2025 2,154
Sept 2025 3,125

Operating Margin Trend (%)

Dec 2025 28.0%
Jun 2025 25.0%
Mar 2025 25.0%
Sept 2025 31.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Sun Pharmaceutical quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5952.5 2,860 689 +7.1% - 24.1% 229.2
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4094.5 3,219 591 +11.3% - 18.4% 233.4
Lupin
Sept 2025 		₹102,578.78 Cr 2295.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1211.9 9,135 1,337 +1.1% - 14.6% 74.9
Cipla
Sept 2025 		₹96,319.77 Cr 1224.4 7,716 1,353 +12.0% - 17.5% 73.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores